Yahoo Finance

FDA Approves Smart Programmer for the InterStim System

Intuitive and Discreet Device Provides Sacral Neuromodulation Therapy for Overactive Bladder and Bowel Incontinence DUBLIN - December 17, 2018 - Medtronic plc (MDT) today announced U.S. Food and Drug ...
PR TIMES

日本メドトロニック World Continence Week 2025に合わせ排尿・排便障害に ...

―2025年6月16日～6月22日World Federation of Incontinence and Pelvic Problems(WFIPP)が制定した「World Continence Week」（ワールド コンチネンス ウィーク）― 日本メドトロニック株式会社（本社：東京都港区）は、過活動膀胱および便失禁の治療を目的とした仙骨神経刺激療法 ...
日本経済新聞

日本メドトロニック、充電式仙骨神経刺激システム「InterStim Micro ...

仙骨神経刺激療法における全身MRI対応システムを実現した 世界最小の充電式デバイス「InterStim(TM)Micro」の販売を開始 日本メドトロニック株式会社（本社:東京都港区）は、難治性の過活動膀胱または便失禁の改善を目的とした充電式仙骨神経刺激システム ...
Yahoo UK & Ireland

Medtronic InterStim System Shows Five-Year Positive Results

One of the world’s largest medical technology, services and solutions companies, Medtronic plc MDT is making efforts to expand its Pelvic Health & Gastric Therapies business, part of the company's ...
Business Insider

Medtronic Begins Post-Market, Real-World Study of the InterStim™ Micro System

ELITE Study Designed to Confirm Long-Term Safety, Efficacy and Patient Benefit of Sacral Neuromodulation with the InterStim™ Micro System for Treatment of Overactive Bladder, Fecal Incontinence and ...
Investing

Medtronic InterStim System Shows Five-Year Positive Results

One of the world’s largest medical technology, services and solutions companies, Medtronic plc (NYSE:MDT) is making efforts to expand its Pelvic Health & Gastric Therapies business, part of the ...
BioWorld

Medtronic’s next-gen Interstim X system wins FDA nod

The FDA has approved Medtronic plc’s next-generation sacral neuromodulation (SNM) system, Interstim X, giving patients a recharge-free option with a 10-year+ lifespan. This newest member of the ...